<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Bio-Rad on Bioecon</title><link>https://en.bioecon.ru/companies/bio-rad/</link><description>Recent content in Bio-Rad on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Sat, 25 Jul 2026 22:12:11 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/companies/bio-rad/index.xml" rel="self" type="application/rss+xml"/><item><title>Invasive-species biomonitoring via eDNA</title><link>https://en.bioecon.ru/technology/edna-invasive-species-biomonitoring/</link><pubDate>Tue, 30 Jun 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/edna-invasive-species-biomonitoring/</guid><description>Detection of invasive and protected species from water, soil and air samples via environmental DNA (eDNA) using droplet-digital PCR and NGS metabarcoding, enabling early-warning biosecurity surveillance for ports, hydropower, ballast water and conservation under the EU Water Framework Directive and NEPA.</description></item><item><title>Wastewater-based epidemiology</title><link>https://en.bioecon.ru/technology/wastewater-based-epidemiology/</link><pubDate>Sun, 28 Jun 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/wastewater-based-epidemiology/</guid><description>Aggregate, non-invasive molecular surveillance of municipal sewage for pathogens, antimicrobial resistance and substance use — an early-warning public-health intelligence service built on viral concentration, droplet-digital PCR and metagenomic sequencing.</description></item><item><title>Downstream Purification &amp; Bioseparation</title><link>https://en.bioecon.ru/technology/downstream-purification-bioseparation/</link><pubDate>Fri, 19 Jun 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/downstream-purification-bioseparation/</guid><description>Downstream purification converts crude bioreactor harvests into clinical-grade drug substance — chromatography (Protein A, IEX, HIC), tangential-flow filtration, and viral clearance together account for &amp;gt;50% of biomanufacturing CAPEX. The global DSP market exceeds $5B and grows at &amp;gt;8% CAGR driven by mAb and cell-gene therapy demand.</description></item></channel></rss>